NMRA Warns of a Possible Medicine Price Hike Amid Rising Costs and Dollar Pressure

The National Medicines Regulatory Authority (NMRA) has warned that medicine prices in Sri Lanka could increase due to rising exchange rates and escalating production-related costs.

According to the Aruna newspaper, NMRA Chairman Ananda Wijewickrama stated that pharmaceutical companies have already requested a price increase of at least 7% for 60 medicines currently under price control. The request has been submitted to Health Ministry Secretary Anil Jasinghe.

Meanwhile, Shantha Bandara, Chairman of the State Pharmaceutical Corporation, pointed out that when price controls were initially introduced, the US dollar was valued at Rs. 295, but had risen to around Rs. 317.5 by March 24, increasing the cost of imports.

He noted that the 60 price-controlled medicines now require at least a 7% price revision, while other imported drugs are also becoming more expensive due to higher production, shipping, and insurance costs, along with anticipated electricity tariff hikes.

Sri Lanka imports approximately 1,800 essential and other medicines, and these rising costs have significantly impacted overall import expenditure, he added.

In addition, the Association of Local Pharmaceutical Manufacturers has also appealed to the Health Ministry for approval to raise prices. Local manufacturers highlighted that increased costs of raw materials, packaging, and production have made price adjustments unavoidable.

They further stated that around 250 medicines are currently produced locally by 13 pharmaceutical companies operating in the country.

Leave a Reply

Your email address will not be published. Required fields are marked *

You cannot copy content of this page